We are live on ! Find out more
NIG

NFJ Investment Group Portfolio holdings

AUM $2.64B
1-Year Est. Return 23.86%
This Fund
S&P 500
This Quarter Est. Return
-3.42%
1 Year Est. Return
+23.86%
3 Year Est. Return
+46.54%
5 Year Est. Return
+49.74%
10 Year Est. Return
AUM
$3.11B
AUM Growth
-$303M
Cap. Flow
-$135M
Cap. Flow %
-4.35%
Top 10 Hldgs %
21.71%
Holding
283
New
12
Increased
29
Reduced
224
Closed
13

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$12.4M
2
LLY icon
Eli Lilly
LLY
+$11.6M
3
JNJ icon
Johnson & Johnson
JNJ
+$11.5M
4
PFE icon
Pfizer
PFE
+$11M
5
AMD icon
Advanced Micro Devices
AMD
+$7.66M

Top Sells

Rank Stock Value
1
UGI icon
UGI
UGI
+$24.6M
2
IDXX icon
Idexx Laboratories
IDXX
+$12.7M
3
WKC icon
World Kinect Corp
WKC
+$11.2M
4
EL icon
Estee Lauder
EL
+$10.2M
5
TGT icon
Target
TGT
+$9.2M

Sector Composition

Rank Sector Weight
1 Financials 24.63%
2 Real Estate 14.08%
3 Healthcare 11.73%
4 Technology 9.5%
5 Industrials 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ODFL icon
276
Old Dominion Freight Line
ODFL
$44.9B
-7
Closed -$1.39K
RTO icon
277
Rentokil
RTO
$12.2B
-13,218
Closed -$330K
TD icon
278
Toronto Dominion Bank
TD
$200B
-7,168
Closed -$453K
UGI icon
279
UGI
UGI
$7.33B
-982,728
Closed -$24.6M
UMC icon
280
United Microelectronic
UMC
$46.9B
-183
Closed -$1.54K
WEN icon
281
Wendy's
WEN
$1.46B
-151,394
Closed -$2.65M
WKC icon
282
World Kinect Corp
WKC
$1.86B
-361,253
Closed -$11.2M
XNCR icon
283
Xencor
XNCR
$1.55B
-50,311
Closed -$1.01M

Similar funds

NFJ Investment Group's Q4 2024 Portfolio in Review

As of Q4 2024, NFJ Investment Group held 283 positions worth $3.11B, down 8.9% from $3.42B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

NFJ Investment Group withdrew a net $135M in Q4 2024, closing 13 positions and reducing 224 holdings. Its most notable exit was UGI, an estimated $24.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 23% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, NFJ Investment Group opened a new position in Bristol-Myers Squibb worth $12.6M.

  • NFJ Investment Group's largest Q4 2024 buy was Bristol-Myers Squibb: 222,089 shares worth $12.6M.
  • NFJ Investment Group added most to Pfizer in Q4 2024, an estimated $11M increase.
  • NFJ Investment Group's biggest Q4 2024 reduction was Idexx Laboratories, cutting an estimated $12.7M.
  • NFJ Investment Group fully exited UGI in Q4 2024, selling an estimated $24.6M.
  • NFJ Investment Group's ten largest holdings make up 22% of its $3.11B portfolio in Q4 2024.
  • NFJ Investment Group opened 12 new positions and closed 13 in Q4 2024.
  • NFJ Investment Group's portfolio value fell 8.9% quarter-over-quarter to $3.11B.

Based on NFJ Investment Group's 13F filing for Q4 2024, filed 13 Feb 2025.